Clinical Study

Pantoea agglomerans in Immunodeficient Patients with Different Respiratory Symptoms

Table 2

Sequenced identified bacteria and the similarity percentage calculated with the BLASTN program.

PatientsCodeBLASTN programMorphology groupSimilarity percentage

              Group 1. HIV positive patients with acute respiratory syndrome

(1)E1Thermoactinomycetes bacteriumCategory D99
(2)NR1bPantoea agglomeransCategory A100
(3)E2Enterococcus faeciumCategory D100
(4)E4Pantoea agglomeransCategory A100
(5)NR5Pantoea agglomeransCategory A99
(6)NR6Bacillus licheniformisCategory B99
(7)NR7Lactobacillus rhamnosusCategory D99
(8)NR8Streptococcus oralisCategory D99
(9)NR9Pantoea agglomeransCategory A99
(10)NR10Streptococcus anginosusCategory D99
(11)E6Lactobacillus rhamnosusCategory D97
(12)NR14Enterobacter hormaecheiCategory D99
(13)NR15Pantoea agglomeransCategory A99
(14)NR17Pantoea agglomeransCategory A100
(15)NR18Enterococcus faeciumCategory D97
(16)NR19Pseudomonas koreensisCategory C99
(17)NR21Pseudomonas azelaicaCategory C99
(18)NR22Pseudomonas azelaicaCategory C99
(19)NR23Pseudomonas azelaicaCategory C99
(20)NR24Pantoea agglomeransCategory A99
(21)NR25Streptococcus oralisCategory E99

                  Group 2. HIV positive patients with TB syndrome

(1)E9Pseudomonas aeruginosaCategory C99
(2)NR41Pseudomonas azelaicaCategory C99
(3)NR42Pantoea agglomeransCategory A99
(4)NR43Pantoea agglomeransCategory A100

                  Group 3. Patients with a TB syndrome

(1)NR36Mycobacterium tuberculosisCategory B100
(2)NR31Pantoea agglomeransCategory A99
(3)NR37Mycobacterium tuberculosisCategory B100

                  Group 4. Reference group

(1)NR51Mycobacterium parascrofulaceumCategory B97
(2)NR52Mycobacterium parascrofulaceumCategory B99
(3)NR53Mycobacterium parascrofulaceumCategory B99
(4)NR54Mycobacterium parascrofulaceumCategory B99